About Stemrx Biosciences
Stemrx Biosciences is a company based in Navi Mumbai (India) founded in 2011. It operates as a D2C and B2C. The company has 7 employees as of March 31, 2022. Stemrx Biosciences offers products and services including Ashwagandha, Immune Plus, Phosphatidylserine, Apigenin, and Pterostillbene. Stemrx Biosciences operates in a competitive market with competitors including Kapiva, ChromaDex, Labomar, Setu and BBetter, among others.
- Headquarter Navi Mumbai, India
- Employees 7 as on 31 Mar, 2022
-
Sectors
HealthcareConsumer
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Stemrx Bioscience Solutions Private Limited
- Date of Incorporation 13 Feb, 2014
- Jurisdiction Navi Mumbai, Maharashtra, India
-
Annual Revenue
$641.25 K (USD)39.36as on Mar 31, 2022
-
Net Profit
$39.49 K (USD)93.95as on Mar 31, 2022
-
EBITDA
$128.6 K (USD)60.16as on Mar 31, 2022
-
Latest Funding Round
-
Investors
-
Employee Count
7
as on Mar 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Stemrx Biosciences
Stemrx Biosciences offers a comprehensive portfolio of products and services, including Ashwagandha, Immune Plus, Phosphatidylserine, Apigenin, and Pterostillbene.
Herbal supplement for stress relief and cognitive support.
Blend to boost immune system and overall health.
Supports memory improvement and cognitive functions.
Promotes skin health and stress reduction benefits.
Aids brain health and cardiovascular support.
Funding Insights of Stemrx Biosciences
Investments & Acquisitions by Stemrx Biosciences
Financial Statements - Stemrx Biosciences
Stemrx Biosciences Comparisons
Competitors of Stemrx Biosciences
Stemrx Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Kapiva, ChromaDex, Labomar, Setu and BBetter, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Ayurvedic healthcare and nutritional products are provided by Kapiva.
|
|
| domain | founded_year | HQ Location |
Nutritional ingredients for health and wellness are developed.
|
|
| domain | founded_year | HQ Location |
Dietary supplements, diet foods, health products, and medical devices
|
|
| domain | founded_year | HQ Location |
Dietary supplements with herbal extracts and vitamins are provided.
|
|
| domain | founded_year | HQ Location |
Nutritional supplements are provided to enhance health and wellness.
|
|
| domain | founded_year | HQ Location |
Nutritional products for various health ailments are provided.
|
Latest news on Stemrx Biosciences
Frequently Asked Questions about Stemrx Biosciences
Stemrx Biosciences was founded in 2011.
Stemrx Biosciences is headquartered in Navi Mumbai, India. It is registered at Navi Mumbai, Maharashtra, India.
As of Mar 31, 2022, the latest employee count at Stemrx Biosciences is 7.
Annual revenue of Stemrx Biosciences is $641.25K as on Mar 31, 2022.
StemRx Biosciences, based in Navi Mumbai, India, is a leader in regenerative medicine and nutraceuticals, offering innovative herbal extracts and dietary supplements. They conduct research, hold patents, and address nutrition gaps through online sales of products like Ashwagandha and Immune Plus. Emphasizing quality and efficacy, they target consumers seeking preventive health solutions with science-backed formulations.
Stemrx Biosciences offers Ashwagandha, Immune Plus, Phosphatidylserine, Apigenin, and Pterostillbene.